KS

Kaziatiyabegam Sayedvikaroddin Kadri

Director DIN 07272467
DIN 07272467 First appointment Aug 2015
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Aug 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Kaziatiyabegam Sayedvikaroddin Kadri

Data last updated:

Kaziatiyabegam Sayedvikaroddin Kadri was an Additional Director at Schwall Pharma Private Limited (from 2015).

DIN 07272467
First Appointment 26 Aug 2015
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Schwall Pharma Private Limited U24233MH2013PTC240600
Additional Director26 Aug 20152013₹9.3 Lakh (FY 2017)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Schwall Pharma Private Limited
Premium access

Shareholding and investment profile for Kaziatiyabegam Sayedvikaroddin Kadri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kaziatiyabegam Sayedvikaroddin Kadri

Kaziatiyabegam Sayedvikaroddin Kadri was first appointed on 26 Aug 2015 as Additional Director at Schwall Pharma Private Limited.

Kaziatiyabegam Sayedvikaroddin Kadri held 1 earlier board appointment: Schwall Pharma Private Limited (Additional Director, from 26 Aug 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available